8 357
Fashion Jobs
SHINE
Senior Account Manager - Paid Search
Permanent · CHENNAI
SHINE
Social Media & Ecommerce Manager
Permanent · HYDERABAD
BENCHMARK SERVICES
Area Sales Manager - Sme Lap With Top Nbfc Company
Permanent · AHMEDABAD
GENIUS CONSULTANTS
Opening For Territory Sales Manager OR Area Business Manager
Permanent · NASHIK
TALISMAN HR SOLUTIONS
Area Sales Manager (Transportation & Logistics Company)
Permanent · AHMEDABAD
AUXIN RECRUITMENT CONSULTANTS
Area Sales Manager | Lap | Hyderabad
Permanent · HYDERABAD
BERGER PAINTS
Area Sales Manager Wood Coating
Permanent · ROHTAK
360 REALTORS
Hiring -Team Leader/ Sales Manager / Relationship Manager| Pune
Permanent · PUNE
LEVI'S
Senior Supply Planner
Permanent · BENGALURU
ADIDAS
Manager -Tech Infrastructure
Permanent · CHENNAI
ADIDAS
Senior Specialist - Finance Operations FP&A
Permanent · CHENNAI
ADIDAS
sr. Manager Merchandising Ecommerce - em Hub
Permanent · GURUGRAM
ADIDAS
sr. Manager- DPC Partner Program
Permanent · GURUGRAM
L'OREAL GROUP
Online Brand Manager
Permanent · MUMBAI
L'OREAL GROUP
Retail And Education Manager - Ysl
Permanent · MUMBAI
JCPENNEY
Senior Manager
Permanent · BENGALURU
DAMYAA PJ FOODS
Area Sales Manager/Regional Sales Manager
Permanent · ROHTAK
ON TIME SOLUTIONS
Branded Fmcg Company Opening For Area Sales Manager in North Kerala
Permanent ·
HECTOR AND STREAK CONSULTING
Sales Engineer / am / Manager - Ups
Permanent · MUMBAI
HDFC LIFE
Hiring For Associate Area Manager-Abp Channel
Permanent ·
SAHAJ PHARMA
Production in Charge - (Synthetic Iron Oxide Pigment)
Permanent · DAHEJ
STONELAM SURFACES LLP
Area Sales Manager- Project Sales
Permanent · CHENNAI
By
Reuters API
Published
Apr 20, 2022
Reading time
2 minutes
Download
Download the article
Print
Text size

J&J suspends sales forecast for COVID vaccine, cuts profit view

By
Reuters API
Published
Apr 20, 2022

Johnson & Johnson on Tuesday cut its full-year profit expectation and said it could no longer provide a forecast for sales of its COVID-19 vaccine because of demand uncertainty as well as surplus supply of other shots.


Johnson & Johnson



The company had earlier predicted as much as $3.5 billion in sales from the single-dose vaccine, which has fared poorly compared to rivals due to low demand in the United States and safety concerns.

The vaccine, which is sold at a "not-for-profit" price, brought in $457 million in the first quarter. Its sales last year had underperformed rival mRNA shots also due to manufacturing bottlenecks and weak global demand.

Pfizer Inc has forecast $32 billion in 2022 sales from its COVID vaccine developed with BioNTech, while Moderna has forecast $21 billion.

J&J now expects full-year adjusted profit forecast to be between $10.15 and $10.35 per share due to a stronger dollar, lower than the prior expectation of $10.40 to $10.60 per share.

Overall first-quarter sales of $23.43 billion missed Refinitiv estimates of $23.61 billion.

"The slight miss was really around the COVID-19 vaccine and quite frankly it met our internal expectations. There was just a disconnect into how the Street assumed it was going to play out over the year," Chief Financial Officer Joseph Wolk told CNBC.

While sales in its consumer health and medical device units beat expectations, sales of $12.87 billion from its large pharmaceuticals unit fell below estimates of $13.6 billion.

J&J warned that supply chain constraints in its consumer health unit would hit sales of its skin health and beauty products for the rest of the year.

Excluding items, J&J earned $2.67 per share, beating market expectation of $2.56 per share.

Citi analyst Joanne Wuensch said the company's earnings "raise more questions than it answers" and investors would be looking for more clarity on the impact of the Russia-Ukraine crisis and soaring inflation.
 

© Thomson Reuters 2024 All rights reserved.

Tags :
Business